US Map / South Carolina
State SC

Clinical Trials in South Carolina

South Carolina is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in South Carolina and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 167 actively recruiting studies with South Carolina sites out of 167 registered in total. The busiest research areas in South Carolina are Heart Failure, Stroke, Depression. Leading sponsors running trials in the state include Medical University of South Carolina, AstraZeneca, VA Office of Research and Development. By stage, South Carolina trials break down as Phase 1 (13), Phase 2 (33), Phase 3 (55), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
167
Recruiting Now
167
← Back to US Map
Top Conditions in South Carolina
Heart Failure (4)Stroke (4)Depression (3)Obesity (3)Solid Tumor (3)Prostate Cancer (3)Diabetic Peripheral Neuropathic Pain (2)Asthma (2)Head and Neck Squamous Cell Carcinoma (2)Colorectal Cancer (2)Head and Neck Neoplasms (2)Carcinoma, Squamous Cell (2)

Frequently Asked Questions — Clinical Trials in South Carolina

How many clinical trials are currently recruiting in South Carolina?
ClinicalMetric currently tracks 167 actively recruiting clinical trials with at least one location in South Carolina. The total number of registered studies—including active but not currently enrolling trials—is 167. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in South Carolina?
South Carolina hosts clinical trials across a broad range of medical conditions, including Heart Failure, Stroke, Depression, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout South Carolina serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in South Carolina?
To join a clinical trial in South Carolina, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in South Carolina maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in South Carolina

NCT05338697 N/A
Recruiting
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future...
Condition
Stroke
Enrollment
657 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT06959524 N/A
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Co...
Condition
Coronary Arterial Disease (CAD)
Enrollment
1,616 pts
Location
United States, Australia, China
Sponsor
Boston Scientific Corporation
View Trial →
NCT07101094 N/A
Recruiting
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Condition
Schizophrenia
Enrollment
300 pts
Location
United States
Sponsor
Bristol-Myers Squibb
View Trial →
NCT05431088 Phase 2, Phase 3
Recruiting
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Condition
Sickle Cell Disease
Enrollment
389 pts
Location
United States, Brazil, India
Sponsor
Pfizer
View Trial →
NCT06001827 N/A
Recruiting
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
Condition
Chronic Kidney Diseases
Enrollment
600 pts
Location
United States
Sponsor
VenoStent
View Trial →
NCT06511141 N/A
Recruiting
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Condition
Overactive Bladder
Enrollment
150 pts
Location
United States
Sponsor
Axonics, Inc.
View Trial →
NCT03486873 Phase 3
Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tum...
Condition
Solid Tumors
Enrollment
3,500 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07146854 N/A
Recruiting
EndoForce Post Approval Study
Condition
End Stage Renal Disease (ESRD)
Enrollment
150 pts
Location
United States
Sponsor
Phraxis, Inc.
View Trial →
NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Pa...
Condition
NonSegmental Vitiligo
Enrollment
180 pts
Location
United States, Canada
Sponsor
Incyte Corporation
View Trial →
NCT06850805 Phase 3
Recruiting
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adole...
Condition
Chronic Rhinosinusitis Without Nasal Polyps
Enrollment
84 pts
Location
United States
Sponsor
Optinose US Inc.
View Trial →
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06296394 N/A
Recruiting
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
Condition
Cystic Fibrosis
Enrollment
146 pts
Location
United States
Sponsor
University of Pittsburgh
View Trial →
NCT05920356 Phase 3
Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab P...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
NCT06883305 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participa...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
990 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
View Trial →
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,250 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT07201922 Phase 3
Recruiting
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in ...
Condition
Familial Pulmonary Fibrosis
Enrollment
80 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
NCT05486234 N/A
Recruiting
CARS: Cannabis and Alcohol Reduction Study
Condition
Cannabis Use
Enrollment
52 pts
Location
United States
Sponsor
Medical University of South Ca
View Trial →
NCT06966700 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Br...
Condition
Breast Neoplasms
Enrollment
2,400 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06911632 N/A
Recruiting
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring ...
Condition
Pulmonary Hypertension
Enrollment
900 pts
Location
United States
Sponsor
Tempus AI
View Trial →
NCT06273904 N/A
Recruiting
Modulating Escape Using Focused Ultrasound
Condition
Anxiety Disorders
Enrollment
40 pts
Location
United States
Sponsor
Medical University of South Ca
View Trial →
NCT05034432 Phase 4
Recruiting
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventri...
Condition
Arrythmia
Enrollment
100 pts
Location
United States
Sponsor
University of Rochester
View Trial →
NCT06585410 Phase 3
Recruiting
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous S...
Condition
Cutaneous Squamous Cell Carcinoma (CSCC)
Enrollment
369 pts
Location
United States, Australia
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT07583459 N/A
Recruiting
Efficacy of Center-based Childcare to Mitigate Unhealthy Weight Gain in Preschoo...
Condition
Obesity & Overweight
Enrollment
300 pts
Location
United States
Sponsor
University of South Carolina
View Trial →
NCT05550298 N/A
Recruiting
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infectio...
Condition
Hematopoietic Cell Transplant
Enrollment
2,000 pts
Location
United States
Sponsor
Arkansas Children's Hospital R
View Trial →
NCT06419205 Phase 2
Recruiting
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097...
Condition
IgA Nephropathy
Enrollment
30 pts
Location
United States, Brazil
Sponsor
Akebia Therapeutics
View Trial →
Page 4 of 7 — 167 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology